New HIV vaccine shows unprecedented success in preclinical study
This HIV vaccine works by prompting the body’s immune system to make substantial numbers of rarely seen “broadly neutralizing” antibodies. In this new study, this vaccine resulted in the best HIV-fighting antibody response ever seen in primates. LJI Professor and Chief Scientific Officer Shane Crotty, Ph.D.
- ▪This HIV vaccine works by prompting the body’s immune system to make substantial numbers of rarely seen “broadly neutralizing” antibodies.
- ▪In this new study, this vaccine resulted in the best HIV-fighting antibody response ever seen in primates.
- ▪LJI Professor and Chief Scientific Officer Shane Crotty, Ph.D.
Hacker News (Front Page) files mainly under programming. We currently carry 689 of its stories. Top-voted stories on Hacker News.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Lji |
| Canonical URL | https://www.lji.org/news-events/news/post/new-hiv-vaccine-shows-unprecedented-success-in-preclinical-study/ |
| Publication time | Tue, 28 Jul 2026 13:12:01 +0000 |
| Retrieval time | 2026-07-28T13:28:04.220Z |
| Last seen | 2026-07-28T13:28:04.220Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | J1Y_b10own_a · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
New HIV vaccine shows unprecedented success in preclinical study Vaccine approach yields high numbers of HIV-neutralizing antibodies in non-human primates Madeline McCurry-Schmidt Science Writer July 6, 2026 Share this Article: Highlights: Scientists at La Jolla Institute for Immunology, Scripps Research have developed an HIV vaccine that trains immune cells to see past HIV’s defenses. This HIV vaccine works by prompting the body’s immune system to make substantial numbers of rarely seen “broadly neutralizing” antibodies. In this new study, this vaccine resulted in the best HIV-fighting antibody response ever seen in primates. Human trials have now started. LJI Professor and Chief Scientific Officer Shane Crotty, Ph.D.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Lji.
Discussion
0 commentsMore from Lji
